BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

  Sanofi’s setback could open the door for rival drugmaker Takeda.

  November 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Cambridge’s Semma Therapeutics Lands $114M for Novel Diabetes Quest

  The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments.

  November 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit

  The company’s head of Development, Joerg Moeller, is taking the reins of the company’s new R&D program.

  November 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  9 Biotechs Facing FDA Decisions in December

  As 2017 comes to a close, 40 drugs have been approved so far, with the record being in 2015, when 46 drugs were approved.

  November 30, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Mettler-Toledo to Begin Layoffs in March, 69 Employees Affected

  Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility.

  November 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Sexual Harassment Scandals Hit Novartis and Pfizer’s Korea Units

  On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September.

  November 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation

  Genmab just received a $20M milestone payment from Janssen Biotech.

  November 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• Gilead Launches Hepatitis C Treatment in China at 20% of U.S. Price

  Gilead priced its Sovaldi treatment for hepatitis C at $8,938 in China - about one-fifth the current price in the U.S.

  November 30, 2017

   · 

  1 min read
• NeoPhore Scientific Founders Publish Breakthrough Immuno-Oncology Discoveries in Nature

  Clinical and now lab data suggest that many cancers with defective DNA repair appear to be highly sensitive to immune surveillance, including when the immune system is modified with agents that disrupt immune “checkpoints”.

  November 30, 2017

   · 

  2 min read
• 

  Deals

  Astellas Takes Out Massachusetts’ Biotech Mitobridge in $390M Deal

  Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013.

  November 30, 2017

   · 

  2 min read

   · 

  Mark Terry